Indications
Therapeutic Asset Ratings
18,135 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Melphalan
Adult Acute Lymphoblastic Leukemia
Roswell Park Cancer Institute
P2
BB
(66)
Melphalan
Aplastic Anemia
Masonic Cancer Center, University of Minnesota
P2
BB
(66)
Melphalan
Childhood Acute Lymphoblastic Leukemia
St. Jude Children's Research Hospital
P2
BB
(66)
Melphalan
Childhood Acute Myeloid Leukemia
Washington University School of Medicine
P2
BB
(66)
Melphalan
Fanconi Anemia
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P2
BB
(66)
Melphalan
Immunodeficiency Disease
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P2
BB
(66)
Melphalan
Prolymphocytic Leukemia
Center for International Blood and Marrow Transplant Research
P2
BB
(66)
Melphalan
Waldenstrom Macroglobulinemia
Roswell Park Cancer Institute
P2
BB
(66)
Melphalan
Wiskott-Aldrich Syndrome
Washington University School of Medicine
P2
BB
(66)
Metformin
Breast Neoplasm
Katherine D. Crew
P2
BB
(66)
Metformin
Melanoma
Dan Zandberg
P2
BB
(66)
Methotrexate
Congenital Amegakaryocytic Thrombocytopenia
Fred Hutchinson Cancer Center
P2
BB
(66)
Minoxidil
Breast Cancer
Ohio State University Comprehensive Cancer Center
P2
BB
(66)
Mitoxantrone
Acute Myeloid Leukemia With Multilineage Dysplasia
Institut de Recherches Internationales Servier
P2
BB
(66)
Nintedanib
Acute Myeloid Leukemia
Northwestern University
P2
BB
(66)
Rocbrutinib
Diffuse Large B-Cell Lymphoma
Guangzhou Lupeng Pharmaceutical Company LTD.
P2
BB
(66)
Romidepsin
Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
Walter Hanel
P2
BB
(66)
Sirolimus
Chronic Myelomonocytic Leukemia
City of Hope Medical Center
P2
BB
(66)
Sirolimus
Epilepsy
Xuanwu Hospital, Beijing
P2
BB
(66)
Tacrolimus
Thalassemia
Memorial Sloan Kettering Cancer Center
P2
BB
(66)
Tazemetostat
Rhabdoid Tumor
Epizyme, Inc.
P2
BB
(66)
Teonanacatl
Chronic Pain Syndrome
Yale University
P2
BB
(66)
Treosulfan
Plasma Cell Myeloma
Insel Gruppe AG, University Hospital Bern
P2
BB
(66)
Veliparib
Small Cell Lung Carcinoma
Central European Society for Anticancer Drug Research
P2
BB
(66)
Vemurafenib
Neoplasm
Seoul National University Bundang Hospital
P2
BB
(66)
Showing 3476 to 3500 of 18,135 assets
Previous
Page 140 of 726
Next